Henry ScheinHSIC -0.91%80 PS Ratio is 0.75 as of Jun. 30, 2026, which is 16% below its 10-year median of 0.89. GuruFocus rates HSIC with a GF Score™ of 80/100 and a GF Value™ of $83.62 (Fairly Valued). The stock has 8 warning signs investors should review. Among 116 Medical Distribution companies, Henry Schein ranks worse than 66.38% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Henry Schein's share price is $83.50.
Henry Schein's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $112.07. Hence, Henry Schein's PS Ratio for today is 0.75.
Warning Sign:
Henry Schein Inc stock PS Ratio (=0.75) is close to 2-year high of 0.81.
The historical rank and industry rank for Henry Schein's PS Ratio or its related term are showing as below:
HSIC'
s PS Ratio Range Over the Past 10 Years
Min: 0.6 Med: 0.89 Max: 1.61
Current: 0.74
During the past 13 years, Henry Schein's highest PS Ratio was 1.61. The lowest was 0.60. And the median was 0.89.
HSIC's PS Ratio is ranked worse than 66.38% of 116
companies
in the Medical Distribution industry
Industry Median: 0.405
vs HSIC: 0.74
During the past 12 months, the average Revenue per Share Growth Rate of Henry Schein was 11.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year.
During the past 13 years, Henry Schein's highest 3-Year average Revenue per Share Growth Rate was 298.90% per year. The lowest was -16.80% per year. And the median was 8.70% per year.
Back to Basics: PS Ratio
Henry Schein (NAS:HSIC) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Henry Schein PS Ratio Related Terms
Henry Schein PS Ratio Historical Data
* Premium members only.
The historical data trend for Henry Schein's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Henry Schein's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's PS Ratio distribution charts can be found below:
* The bar in red indicates where Henry Schein's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Henry Schein's PS Ratio for today is calculated as
Henry Schein's Share Price of today is $83.50. Henry Schein's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $112.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Henry Schein (HSIC) has a PS Ratio of 0.75 as of Jun. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Henry Schein and its competitors. This is 16% below median its historical median of 0.89. Over the past decade, Henry Schein's PS Ratio has ranged from 0.60 to 1.61. According to the industry distribution chart, Henry Schein ranks #77 out of 116 companies in the Medical Distribution industry, placing it in the top 66.4%.
Is Henry Schein's PS Ratio too high?
Henry Schein's current PS Ratio of 0.75 is 16% below median its 10-year median of 0.89. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 1.61. The Medical Distribution industry median PS Ratio is 0.41. Henry Schein's value of 0.75 is 85.2% above this industry median. Based on the distribution chart, Henry Schein ranks #77 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Henry Schein has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's PS Ratio compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #77 out of 116 companies for PS Ratio. This places Henry Schein in the lower half of its industry. The industry median PS Ratio is 0.41. Henry Schein's value of 0.75 is 85.2% above this benchmark. Historically, Henry Schein's own PS Ratio has ranged from 0.60 to 1.61 over the past decade. While the company's 10-year median is 0.89 vs. the industry median of 0.41, Henry Schein has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.41, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current PS Ratio of 0.75 is 85.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current PS Ratio is 0.75, which is 16% below median its own 10-year median of 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.62, compared to a current price of $83.50 — trading 0.1% below its estimated fair value. The current PS Ratio is 0.75, which is 16% below median its 10-year median of 0.89 and 85.2% above the Medical Distribution industry median of 0.41. Henry Schein's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Henry Schein (HSIC), the current PS Ratio is 0.75 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be undervalued.
The current stock price of $83.50 is trading 0.1% below its estimated GF Value™ of $83.62.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
PS Ratio: 0.75 (16% below median its 10-year median of 0.89)
GF Value™: $83.62 vs. price of $83.50 (0.1% below fair value)
Industry Position: 85.2% above the Medical Distribution median (#77 of 116)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score
Get the complete analysis for HSIC
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
